Diabetes

ORLANDO — In this video exclusive, James R. Gavin III, MD, PhD, Healio | Endocrine Today Co-editor, talks with Camille Powe, MD, about use of continuous glucose monitoring during pregnancy for women with type 1 diabetes.

A 5:2 intermittent fasting diet combined with meal replacement resulted in greater weight loss and better glycemic control compared with antidiabetic medications in patients with early-stage type 2 diabetes, data from the EARLY study showed.

ORLANDO — Since 2005, an Irish diabetes in pregnancy program has steadily improved pregnancy and neonatal outcomes through extensive research and development of services for care before, during and after pregnancy.

ORLANDO — Adding continuous glucose monitoring to hospital standard of care does not appear to improve glycemic control for adults with type 2 diabetes, according to results of the TIGHT study.

ORLANDO — Semaglutide reduces risk for cardiovascular events among adults with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or change in HbA1c, according to data from the SELECT trial.

Eating disorder symptoms and insulin omission appeared prevalent among patients with insulin-dependent diabetes, with more women and girls presenting with eating disorder symptoms, according to data published in Eating Behaviors.

ORLANDO — Semaglutide use was associated with significant reductions in worsening of kidney disease, cardiovascular events and all-cause death vs. placebo for adults with type 2 diabetes regardless of concomitant use of SGLT2 inhibitors.

Women with chronic pelvic pain have more ED visits, imaging tests and hysterectomies and higher rates of overlapping chronic pain conditions vs. women without chronic pelvic pain, according to findings published in Obstetrics & Gynecology.

ORLANDO — An international consensus group has offered the first guidance for clinicians about how to monitor people who test positive for islet autoantibodies, indicating high risk for developing type 1 diabetes.

ORLANDO — Adults with type 1 diabetes had larger reductions in HbA1c using a mobile app that made recommended adjustments to insulin therapy than users who did not receive weekly adjustments, according to a speaker.